Guide

Donor Eligibility, Look-Back and Deviation: The Cross-Cutting Spine for Blood, Tissue and Cell Therapy

Whatever the framework — 21 CFR 606 for blood, 21 CFR 1271 for HCT/P, Directive 2004/23/EC for EU tissue, FACT-JACIE for cellular therapy — the same three records must be defensible: the donor eligibility determination at the front of the chain, the look-back triggered by a post-donation positive test or recipient adverse outcome, and the deviation/adverse reaction report with its regulatory clock. Inspection findings on these records are inspection findings on every framework. This guide is the cross-cutting spine — close these once and they close on all the others.

Start free trial Free trial, no credit card, onboard in days, not months.

Donor eligibility as one integrated record

Across 21 CFR 630 (blood), 21 CFR 1271 Subpart C (HCT/P), Directive 2006/17/EC (EU tissue) and the FACT-JACIE donor sections, the eligibility determination is the same logical record: medical history + physical assessment + infectious disease test panel + risk factor assessment + the determining person's signed determination. Recurring finding across every framework: the components exist in separate files but the integrated signed determination is missing, undated, or pre-dates the testing results. The inspector reads the determination, not the components.

Look-back: the post-donation event and the recipient chain

Look-back is triggered by two event types — a post-donation positive test on a repeat donor (look forward to all units released since the prior negative), and a recipient adverse outcome that implicates a unit (look back to the donor and any other recipients from the same donor). Across 21 CFR 610.46/47, 1271.350, EU SARE notifications and FACT-JACIE, the rules differ on timing and notification scope but the core workflow is identical. A bank without a tested look-back workflow has a finding waiting to happen — it is not a question of if but when.

The reporting clocks across frameworks

21 CFR 606.170: fatality reports within 24 hours by phone/email. 21 CFR 606.171 BPDR: Form 3486 within 45 calendar days of discovery. 21 CFR 1271.350: HCT/P adverse reaction reports on Form 3500A within 15 calendar days of receipt. EU SARE: serious adverse reactions and events notifications per national competent authority timelines (typically rapid notification within 24–48 hours plus full report). FACT-JACIE: programme-level reporting plus regulatory reporting per applicable framework. The clocks are calendar days from the documented trigger — not from the decision to report.

Deviation, root cause and the difference between a deviation and a non-event

Not every deviation is a reportable event. The evaluation against 606.171/1271.350/EU SARE criteria is the gating decision — and that decision is itself a record the inspector reads. A deviation log that closes events as 'no impact' without a documented framework evaluation is a finding regardless of whether the underlying judgement was correct. Conversely, a deviation log that over-reports reaches FDA's BPDR rate flag for the wrong reason. The discipline is the documented evaluation, not the conclusion.

A 45-day readiness path for the spine alone

Days 1–10: integrated determination audit across every donor type the programme handles. Days 11–25: look-back workflow rehearsal — pick a real historical event and walk it through end-to-end. Days 26–35: reporting clock audit — pull last 12 months of deviations and check the clock-discipline for each. Days 36–45: framework evaluation audit and internal closure review.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

Donor eligibility

The formal, documented determination — risk assessment plus IDM testing — that a donor's blood or tissue donation may be released for clinical use.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Modules that do the work

Cross-framework spine

Same workflow, framework-aware overlays.

Reporting clocks

Right clock and form per framework.

Look-back workflow

One button, full chain surfaced.

Industries this hits hardest

Blood & tissue

Frequently asked

Does the BPDR clock start at discovery or at root cause?

Discovery. 21 CFR 606.171 sets the clock from the date on which the establishment first becomes aware of information reasonably suggesting that a reportable event has occurred. A clock started at the root-cause meeting is a recurring finding.

If a deviation is judged not reportable, is the evaluation still recorded?

Yes — the evaluation against the reportability criteria is itself the deliverable. A deviation log that closes events without a documented evaluation is a finding even when the underlying judgement was correct.

How does look-back work for an unrelated cord blood unit?

If the maternal donor returns positive on a subsequent test, every cord blood unit from that donor still in inventory is quarantined, and any unit already released triggers notification to the receiving transplant centre. The 6-month follow-up infant assessment factors into the look-back evaluation.

Are EU SARE notifications harmonised?

The framework (Directives 2002/98 for blood, 2004/23 for tissues and cells) is harmonised across the EU but national competent authorities set the precise notification timelines and channels. Multi-country operators run a notification matrix per member state.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →